Bill Sponsors: KS SB212 | 2025-2026 | Regular Session

Bill Title: Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2025-02-06 - Senate Referred to Committee on Financial Institutions and Insurance [SB212 Detail]

Text: Latest bill text (Introduced) [PDF]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Senator Dinah Sykes [D]PrimarySponsored BillsSD-021FollowTheMoneyBallotpediaVoteSmart

Social Comments on KS SB212

feedback